Comtifator clinical trials
Also written BMS-986419.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2023
How each study uses comtifator is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
4 studies that test it; most in 2023 (3)
| Year | Studies |
|---|---|
| 2023 | 3 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
Who runs them
Industry 4 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses comtifator is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- A Study to Investigate the Safety, Tolerability, and Drug Levels of BMS-986419 (Part 1) and the Effects Multiple Doses of BMS-986419 on Cardiac Repolarization (Part 2) in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT06846866Written as BMS-986419
- A Study to Assess the Bioavailability and Effect of Food of BMS-986419 Immediate-release Tablet Formulation in Healthy Adult ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05963932Written as BMS-986419 DR Capsule
- A Study to Assess the Effect of BMS-986419 on the Single Dose Drug Levels of Probe Substrates in Healthy ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05932277Written as BMS-986419
- A Study to Evaluate the Absorption, Metabolism, and Excretion of [14C]BMS-986419 in Healthy Male ParticipantsCompletedPhase 1Bristol-Myers SquibbNCT05847439Written as [14C]BMS-986419
Codes
What other systems call comtifator · ClinicalTrials.gg INT018471
- UNII (FDA) XJ83R4LQ52COMTIFATOROne source FDA
- NCI Thesaurus C215243ComtifatorOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | XJ83R4LQ52 | COMTIFATOR | One source FDA |
| NCI Thesaurus | C215243 | Comtifator | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.